Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer. Develtere D, Tsantoulis P, Olivier T. Eur J Cancer 2026;240:116740.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Develtere D, Tsantoulis P, Olivier T. Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer. Eur J Cancer 2026;240:116740.
PMID: 42019224